Found: 7

Select item for more details and to access through your institution.

  • Takeda's second bet on DARTs.

    Published in:
    Nature Biotechnology, 2014, v. 32, n. 11, p. 1070, doi. 10.1038/nbt1114-1070a
    Publication type:
    Article

  • Gilead widens cancer focus.

    Published in:
    Nature Biotechnology, 2013, v. 31, n. 2, p. 90, doi. 10.1038/nbt0213-90b
    By:
    • Allison, Malorye
    Publication type:
    Article

  • Perspective: Testing failures.

    Published in:
    Nature, 2012, v. 485, n. 7398, p. S17, doi. 10.1038/485S17a
    By:
    • Mandrup-Poulsen, Thomas
    Publication type:
    Article

  • Combo antibody efforts up, despite regulatory uncertainties.

    Published in:
    Nature Medicine, 2011, v. 17, n. 8, p. 907, doi. 10.1038/nm0811-907
    By:
    • Khamsi, Roxanne
    Publication type:
    Article

  • Boehringer splashes out on bispecific antibody platforms.

    Published in:
    Nature Biotechnology, 2011, v. 29, n. 1, p. 5, doi. 10.1038/nbt0111-5
    By:
    • Moran, Nuala
    Publication type:
    Article

  • People.

    Published in:
    Nature Biotechnology, 2002, v. 20, n. 5, p. 521, doi. 10.1038/nbt0502-521
    Publication type:
    Article

  • MacroGenics.

    Published in:
    Nature Biotechnology, 2001, v. 19, p. BE12, doi. 10.1038/89384
    By:
    • Fletcher, Liz
    Publication type:
    Article